🇺🇸 FDA
Patent

US 12054501

Compositions and methods for inhibiting arginase activity

granted A61KA61K2039/507A61K2300/00

Quick answer

US patent 12054501 (Compositions and methods for inhibiting arginase activity) held by Precision Pharmaceuticals, Inc. expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Pharmaceuticals, Inc.
Grant date
Tue Aug 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/507, A61K2300/00, A61K31/4245, A61K31/69